Arteris  on May 10, 2023


Balanced News   View All Sources

Evaluation of health utility in trial-based cost-utility analyses for major cardiovascular disease: protocol for a systematic review

health

Introduction The global incidence of cardiovascular disease (CVD) is high, and the medical costs associated with its management have been increasing. Cost–utility analyses (CUAs) are essential for understanding the value of healthcare interventions and for decision-making. A majority of the CUAs for CVD are model based and have cited health utilities from previously published data; standard health utilities for the CUAs of CVD have not been established yet. Thus, we aim to identify the standard utilities according to the patients’ condition and disease severity in patients with major CVDs. Methods and analysis We will search Medline and Evidence-Based Medicine Reviews for trial-based CUA studies that have reported on quality-adjusted life-years using original health utilities for patients ...

BMJ     May 10, 2023